RMFEX
Price
$53.89
Change
+$3.35 (+6.63%)
Updated
Apr 9 closing price
Net Assets
92.19B
YAFIX
Price
$17.92
Change
+$1.03 (+6.10%)
Updated
Apr 9 closing price
Net Assets
2.34B
Ad is loading...

RMFEX vs YAFIX

Header iconRMFEX vs YAFIX Comparison
Open Charts RMFEX vs YAFIXBanner chart's image
American Funds American Mutual R4
Price$53.89
Change+$3.35 (+6.63%)
VolumeN/A
Net Assets92.19B
AMG Yacktman Focused I
Price$17.92
Change+$1.03 (+6.10%)
VolumeN/A
Net Assets2.34B
RMFEX vs YAFIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFEX vs. YAFIX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFEX is a Buy and YAFIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 92.2B vs. YAFIX (2.34B). YAFIX pays higher dividends than RMFEX: YAFIX (2.01) vs RMFEX (1.61). RMFEX was incepted earlier than YAFIX: RMFEX (23 years) vs YAFIX (13 years). YAFIX (1.06) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. YAFIX (4.00). RMFEX has a lower initial minimum investment than YAFIX: RMFEX (250) vs YAFIX (100000). RMFEX annual gain was more profitable for investors over the last year : -4.11 vs. YAFIX (-20.56). RMFEX return over 5 years is better than : 47.69 vs. YAFIX (15.15).
RMFEXYAFIXRMFEX / YAFIX
Total Expense Ratio0.621.0658%
Annual Report Gross Expense Ratio0.621.0658%
Fund Existence23 years13 years-
Gain YTD-7.620-8.20793%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets92.2B2.34B3,947%
Annual Yield % from dividends1.612.0180%
Returns for 1 year-4.11-20.5620%
Returns for 3 years0.28-14.88-2%
Returns for 5 years47.6915.15315%
Returns for 10 years51.93-25.17-206%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTMUX18.84N/A
N/A
Goldman Sachs Small/Mid Cap Growth R6
SVBCX26.00N/A
N/A
JHancock Balanced C
SHPCX12.06N/A
N/A
Saratoga Health & Biotechnology C
FMEFX32.64N/A
N/A
Nuveen Small/Mid Cap Growth Opp R6
MRGEX19.44N/A
N/A
Morgan Stanley Inst Emerging Mkts IR